Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest?
(2024) Acta Gastro-Enterologica Belgica — Vol. 87, n° 2, p. 344-345 (2024)
Files
ActaGastroBelg2024MASLDSchistosoma.pdf
Open Access - Adobe PDF
- 552.98 KB
Details
- Authors
- Abstract
- The world of hepatology has been recently shaken by a much-needed change of nomenclature validated by a large expert consensus. This consensus finally adopts positive diagnostic criteria for the recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD). This change in nomenclature is supported by scientific arguments published in the Acta Gastro-Enterologica Belgica. However, making the diagnosis of MASLD easy on the basis of the coexistence of hepatic steatosis (by imaging or histology) and just one cardiometabolic criterion instead of a diagnosis of exclusion must not relegate other causes of chronic liver diseases to second place.
- Affiliations
Citations
Henin, G., Baldin, P., Frans, C., Havelange, V., Delire, B., Yombi, J. C., & Lanthier, N. (2024). Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest? Acta Gastro-Enterologica Belgica, 87(2), 344-345. https://doi.org/10.51821/87.2.13087 (Original work published 2024)